GPT Healthcare Ltd Cash Flow Conversion Efficiency
GPT Healthcare Ltd cash flow conversion efficiency. Based on the latest financial reports, GPT Healthcare Ltd (GPTHEALTH) has a cash flow conversion efficiency ratio of 0.113x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs195.91 Million ≈ $2.12 Million USD) by net assets (Rs1.73 Billion ≈ $18.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of GPT Healthcare Ltd (2017–2025)
Cash flow conversion efficiency of GPT Healthcare Ltd from 2017 to 2025. This chart illustrates how GPT Healthcare Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for GPT Healthcare Ltd for real-time trading data and today's change.
GPT Healthcare Ltd Cash Flow Conversion Ratio Explained
GPT Healthcare Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
GPT Healthcare Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GPT Healthcare Ltd ranked by their cash flow conversion efficiency. Also see GPT Healthcare Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MODISON LIMITED
NSE:MODISONLTD
|
0.021x |
|
Eastech Holding Limited
TW:5225
|
0.058x |
|
Unic Technology
TWO:5452
|
-0.104x |
|
Arrow Greentech Limited
NSE:ARROWGREEN
|
0.189x |
|
Caisse Reg Cred Agric Mut Tourain Poitou
PA:CRTO
|
-0.020x |
|
Harbour Link Group Bhd
KLSE:2062
|
0.023x |
|
Niu Technologies
F:0O9
|
N/A |
|
Western Forest Products Inc
TO:WEF
|
0.000x |
Annual Cash Flow Conversion Efficiency for GPT Healthcare Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of GPT Healthcare Ltd from 2017 to 2025. Review GPT Healthcare Ltd (GPTHEALTH) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | Rs2.69 Billion ≈ $29.14 Million |
Rs820.08 Million ≈ $8.87 Million |
0.304x | +11.94% |
| 2024-09-30 | Rs2.48 Billion ≈ $26.80 Million |
Rs673.96 Million ≈ $7.29 Million |
0.272x | -13.65% |
| 2023-09-30 | Rs2.18 Billion ≈ $23.63 Million |
Rs688.00 Million ≈ $7.44 Million |
0.315x | -21.53% |
| 2022-09-30 | Rs1.65 Billion ≈ $17.88 Million |
Rs663.55 Million ≈ $7.18 Million |
0.401x | -3.82% |
| 2021-09-30 | Rs1.58 Billion ≈ $17.11 Million |
Rs659.92 Million ≈ $7.14 Million |
0.417x | +27.17% |
| 2020-09-30 | Rs1.34 Billion ≈ $14.48 Million |
Rs439.28 Million ≈ $4.75 Million |
0.328x | +0.34% |
| 2019-09-30 | Rs1.27 Billion ≈ $13.72 Million |
Rs414.65 Million ≈ $4.48 Million |
0.327x | +16.91% |
| 2018-09-30 | Rs1.16 Billion ≈ $12.53 Million |
Rs323.90 Million ≈ $3.50 Million |
0.280x | +26.48% |
| 2017-09-30 | Rs1.01 Billion ≈ $10.90 Million |
Rs222.77 Million ≈ $2.41 Million |
0.221x | -- |
About GPT Healthcare Ltd
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiolog… Read more